how much weight loss glp-1 Rx Trends: Real-World Data on GLP-1s for Understanding GLP-1 and Its Role

RCTs of the original is-CGM devices are more mixed but observational data are supportive of their use

Your weight syncs to your care team on its own, no app, no Wi-Fi setup, no logging

Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice

Healthy eating index diet quality in randomized weight loss trials: a systematic review

Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia

Adverse events in relation to GLP-1R agonists for the treatment of obesity are mainly gastrointestinal side effects, including nausea, diarrhoea, vomiting and constipation, which is consistent with observations in type 2 diabetes, and rates of discontinuation due to adverse events are generally higher with GLP-1R agonists treatment compared with placebo [26, 30,31,32,33,34,35,36,37,38,39]